期刊文献+

反相高效液相色谱法检测人血浆帕珠沙星浓度 被引量:1

Determination of Pazufloxacin in Human Plasma by RP-HPLC
下载PDF
导出
摘要 目的:建立人血浆帕珠沙星检测的高效液相色谱方法。方法:血浆经高氯酸沉淀,以Agilent TC-C_(18)为色谱柱;流动相为乙腈-0.1%三氟乙酸-水体系,流速为0.8 ml·min^(-1);检测波长314 nm。结果:帕珠沙星浓度在0.10~20.00 mg·L^(-1)范围内线性关系良好(r=0.999 8);高中低三个浓度(0.25,5.00,15.00 mg·L^(-1))的相对回收率分别为(101.47±4.53)%、(99.50±3.63)%和(100.71±3.33)%;日内RSD分别为3.12%、2.85%和2.63%,日间RSD分别为4.18%、3.29%和2.81%。结论:该方法简便、快速、准确可靠,适用于人血浆帕珠沙星浓度的测定及其药物动力学研究。 Objective: To develop an HPLC method for the determination of pazufloxacin in human plasma. Method: The human plasma samples were precipitated by perchloric acid. The analytical column was packed with an Agilent TC-C18 column. The mobile phase was acetonitrile-0. 1% trifluoroacetic acid-water and the flow rate was 0. 8 ml·min^-1. The UV detection wavelength was 314 nm. Result: Excellent linear relationship was obtained within the range of 0. 10 mg·min^-1to 20. 00 mg. L^- 1 (r = 0. 999 8 ). The relative recovery was ( 101.47 ± 4. 53 ) % , (99. 50 ± 3.63 ) % and ( 100. 71 ± 3.33 ) % , respectively for three concentrations (0. 25,5.00, 15.00 mg.L^-1 ) ,the intra-day RSD was 3.12% ,2. 85% and 2. 63% ,and the inter-day RSD was 4. 18% ,3.29% and 2. 81% ,respectively. Conclusion: The method is simple, rapid and accurate which can be used to determine pazufloxacin in human plasma and study its nharmacokinetics.
出处 《中国药师》 CAS 2011年第9期1304-1305,共2页 China Pharmacist
关键词 帕珠沙星 药物动力学 高效液相色谱法 Pazufloxacin Pharmacokinetics HPLC
  • 相关文献

参考文献5

二级参考文献26

共引文献29

同被引文献16

  • 1裴斐,李芹,方翼,柴栋,梁蓓蓓,童卫杭,王睿.中国健康志愿者单剂静脉滴注甲磺酸帕珠沙星注射液药动学研究[J].中国抗生素杂志,2006,31(10):627-630. 被引量:1
  • 2王进,肖永红,张薇,吕媛,康子胜,张明,刘燕,夏亚红,李天云.多剂量甲磺酸帕珠沙星氯化钠注射液在健康人体的药代动力学[J].中国临床药理学杂志,2007,23(1):24-27. 被引量:4
  • 3Lou S, Li W, Hu Q. Influence of cefoperazone and azithromycin onthe pharmacokinetics of pazufloxacin in rats[J]. Eur J Drug MetabPharmacokinet, 2007,32(4): 219-23.
  • 4Choi YJ, Heo SH, Lee JM, et al. Identification of azurocidin as apotential periodontitis biomarker by a proteomic analysis ofgingival crevicular fluid[j]. Proteome Sci, 2011, 9: 42.
  • 5蒋一,刘洪臣,吴霞,等.健康志愿者龈沟液中头孢哌酮注射液药物浓度的检测[J]. 口腔领面修复学杂志,2009, 10(5): 261-4.
  • 6Minami S, Hattori R, Matsuda A. Pharmacological properties andexpected clinical role of an injectable new quinolone antibiotic,pazufloxacin mesilate [J]. Nihon yakurigaku zasshi. Foliapharmacologica Japonica, 2003, 122(2): 161-78.
  • 7陆林译.AmitavaDasgupta原著.药物监测方法:治疗性用药与药物滥用[M].北京:人民卫生出版社,2011: 1-3.
  • 8Liu J, Duan Y. Saliva: a potential media for disease diagnostics andmonitoring[j]. Oral Oncol, 2012, 48(7): 569-77.
  • 9CakicS. Gingival crevicular fluid in the diagnosis of periodontaland systemic diseases [J]. Srp Arh Celok Lek, 2009,137(5-6):298-303.
  • 10Bastos AS, Loureiro AP, de Oliveira TF, et al. Quantitation ofmalondialdehyde in gingival crevicular fluid by a high-performanceliquid chromatography-based method[j]. Anal Biochem, 2012,423(1): 141-6.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部